| pubmed-article:2214764 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2214764 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:2214764 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2214764 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:2214764 | lifeskim:mentions | umls-concept:C0701303 | lld:lifeskim |
| pubmed-article:2214764 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:2214764 | pubmed:dateCreated | 1990-11-21 | lld:pubmed |
| pubmed-article:2214764 | pubmed:abstractText | Ovarian cells of pregnant rats were cultured with synthetic progestins (R5020, R2323), dexamethasone and RU486. Progesterone and 20 alpha-hydroxy-pregn-4-en-3-one (20 alpha-dihydroprogesterone) in the medium were measured by specific radioimmunoassay. Both R5020 and R2323 increased concentrations of these intrinsic progestins. RU486 decreased concentrations of progesterone, however, the addition of R5020 or R2323 counteracted this action. Immature hypophysectomized rats treated with pregnant mare serum gonadotropin (PMS) and human chorionic gonadotropin (hCG) were administered with RU486; the serum levels of progesterone and 20 alpha-dihydroprogesterone tended to decrease. R5020 and R2323 inhibited the effect of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), whereas RU486 did not. Inhibition of the cholesterol side chain cleavage enzyme (CSCC) by RU486 was more marked than that by R5020 or R2323. These results show that RU486 decreases progesterone synthesis in cultured ovarian cells. A part of the mechanism may involve an inhibition of CSCC. | lld:pubmed |
| pubmed-article:2214764 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2214764 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2214764 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2214764 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:2214764 | pubmed:issn | 0022-4731 | lld:pubmed |
| pubmed-article:2214764 | pubmed:author | pubmed-author:AraiKK | lld:pubmed |
| pubmed-article:2214764 | pubmed:author | pubmed-author:OkinagaSS | lld:pubmed |
| pubmed-article:2214764 | pubmed:author | pubmed-author:ArakawaSS | lld:pubmed |
| pubmed-article:2214764 | pubmed:author | pubmed-author:KambegawaAA | lld:pubmed |
| pubmed-article:2214764 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2214764 | pubmed:day | 14 | lld:pubmed |
| pubmed-article:2214764 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:2214764 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2214764 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2214764 | pubmed:pagination | 479-83 | lld:pubmed |
| pubmed-article:2214764 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:meshHeading | pubmed-meshheading:2214764-... | lld:pubmed |
| pubmed-article:2214764 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2214764 | pubmed:articleTitle | Luteolytic effect of the antiprogestin and antiglucocorticoid agent RU486 in rats. | lld:pubmed |
| pubmed-article:2214764 | pubmed:affiliation | Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan. | lld:pubmed |
| pubmed-article:2214764 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2214764 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
